The promise of “Bring Your Own Device” (BYOD) in clinical trials has sparked equal parts excitement and skepticism across the research community. Supporters point to greater patient convenience, faster recruitment and potential cost savings. Critics raise concerns about data integrity, regulatory acceptance and technology disparities. So — where does the truth stand?
In this webinar, the featured speakers will move beyond the buzzwords and dig into the real-world evidence shaping BYOD adoption in ePRO and eCOA studies.
The expert panel will explore:
- The State of BYOD in Clinical Trials – Understanding adoption trends, identifying therapeutic areas where BYOD thrives and confronting its current limitations
- Data Quality & Integrity – Addressing device variability, OS updates, offline data capture and how to meet regulatory expectations without sacrificing flexibility
- Patient-Centricity: Promise vs. Reality – Reviewing whether BYOD truly improves recruitment, retention and compliance — or if it widens the accessibility gap
- Regulatory & Privacy Considerations – Navigating HIPAA, GDPR and global frameworks, informed consent requirements and the critical role of submission screenshots
Sponsors, CROs, technology providers and clinical operations professionals will gain clarity on separating hype from reality, understanding the evolving regulatory landscape and evaluating if BYOD is the right fit for upcoming trials.
Register for this webinar to learn how BYOD in clinical trials is shaping data quality, patient engagement and regulatory strategy.
Speakers
(Moderator) Megan Petrylak, Chief Operating Officer, Clinical ink
With over 17 years of clinical trial experience, including 14 years in operational leadership roles, Megan Petrylak plays a key role at Clinical ink. She oversees all customer, site and patient-facing operations, enhancing Clinical ink’s capabilities in data management and quality assurance. Her commitment to fostering a quality-first culture has led to remarkable improvements in customer satisfaction, reduced study build and execution times and outstanding quality outcomes.
Megan has a proven track record in driving successful Phase I-III clinical trials for a diverse range of global biopharmaceutical companies and contract research organizations (CROs). Before joining Clinical ink in 2018, she served as Director of Project Delivery at Worldwide Clinical Trials and previously led Bioclinica’s eClinical project management and support services.
Read more...
Read Less...
Vicki Gashwiler, Global Head, Clinical Operations, ProPharma
Vicki Gashwiler is the Head of Global Clinical Operations at ProPharma. With over 20 years of global clinical operations experience, Vicki leads the operations team to deliver first-in-human/Phase I through late-stage/post-market clinical trials for both pharmaceutical and medical devices.
Message Presenter
Clare Campbell-Cooper, Global Head of Digital Health and Innovation, Fortrea
Clare Campbell-Cooper joined Fortrea in February 2020 and serves as its Global Head of Digital Health and Innovation. Clare has over 25 years of industry experience and is a recognized leader within the field of digital health. Clare has a wealth of experience encompassing many disciplines within clinical research and has held management positions within Data Management, Clinical Monitoring, Phase I Operations, Strategy and Planning, Project Management and most recently Digital Health.
Clare is an active member of several boards and associations and sees that working in a pre-competitive environment is critical to helping drive change within the industry. Clare is passionate about how we can change clinical trials for the better and is a member of the Fortrea Environmental Sustainability Committee and a Founding Member of the Fortrea Sustainable Future Chapter. Clare sits on the King’s College London Scientific Advisory Board, Centre for Pharmaceutical Medicine Research and is a visiting lecturer at KCL.
Read more...
Read Less...
Lyndsay Garrison, eCOA Vendor Relationships and Strategy, Abbvie
Info coming soon…
Message Presenter
Karen Sondergaard, Senior Clinical Operations Lead, Novo Nordisk
Info coming soon…
Message PresenterWho Should Attend?
This webinar will appeal to:
- Medium-to-large pharma and CROs
- Medical device manufacturers
- Director/VP/Head of Precision Medicine
- Chief Medical Director
- Director/VP/Head of Digital Innovation/Engagement
- Scientists, Engineers and Data Scientists
What You Will Learn
Attendees will gain insight into:
- The current landscape of BYOD adoption across therapeutic areas and geographies
- Key technical and regulatory risks tied to device variability and offline data capture
- How BYOD affects patient recruitment, retention and compliance — and whether it introduces new accessibility challenges
Xtalks Partner
Clinical ink
Clinical ink is a global life science company bringing data, technology, and patient-centric research together. Our deep therapeutic-area expertise, coupled with Direct Data Capture, eCOA, behavioral and dropout prediction, eConsent, telehealth, and digital biomarkers advancements (including use of Continuous Glucose Monitoring for detection of hypoglycemia), support the next generation of clinical trials and ultimately the clinical management of patients.
You Must Login To Register for this Free Webinar
Already have an account? LOGIN HERE. If you don’t have an account you need to create a free account.
Create Account